GovChime
Notice ID: d2713ea231544d89b653a39e3fbe278eSolicitation

Bupropion HCL ER

Responses closed . Full description on SAM.gov.

Overview

Response deadline
3:00 PM EST
Posted
September 15, 2025
Notice type
Solicitation
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of WarDEFENSE LOGISTICS AGENCY

Notice details

Office
TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
PSC
6505: DRUGS AND BIOLOGICALS
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
SPE2D2-21-R-0105
Notice ID
d2713ea231544d89b653a39e3fbe278e

Description

Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract.

Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation.

Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract.

Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.

BUPROPION HCL ER NATIONAL CONTRACTS SOLICITATION

Full description on SAM.gov

Award Overview

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (15)

  • Modification P00008 SPE2D223D0002 Option Year 3.PDF

    25 KBAdded in Solicitation version 6Posted
    Download
  • Modification P00007 SPE2D223D0002.PDF

    197 KBAdded in Solicitation version 6Posted
    Download
  • Modification P00006 SPE2D223D0002 Option Year 2.PDF

    25 KBAdded in Solicitation version 5Posted
    Download
  • Modification P00005 SPE2D223D0002.PDF

    188 KBAdded in Solicitation version 5Posted
    Download
  • Signed SPE2D223D0002 P00003.pdf

    175 KBAdded in Solicitation version 5Posted
    Download
  • SF30_SPE2D223D0002P00004.PDF Signed.pdf

    18 KBAdded in Solicitation version 5Posted
    Download
  • Revised Schedule of Supplies.pdf

    112 KBAdded in Solicitation version 5Posted
    Download
  • Bilaterally Signed SPE2D223D0002 P00001.pdf

    193 KBAdded in Solicitation version 5Posted
    Download
  • Bilaterally Signed Bupropion HCL ER Award SPE2D2-23-D-0002.pdf

    375 KBAdded in Solicitation version 5Posted
    Download
  • SPE2D221R0105 0002.pdf

    104 KBAdded in Solicitation version 4Posted
    Download
  • REVISED Page 104 Appendix B.pdf

    104 KBAdded in Solicitation version 3Posted
    Download
  • REVISED Pages 39 to 40.pdf

    126 KBAdded in Solicitation version 3Posted
    Download
  • REVISED Page 2 Schedule of Supplies.pdf

    68 KBAdded in Solicitation version 3Posted
    Download
  • SPE2D221R0105 0001.pdf

    136 KBAdded in Solicitation version 3Posted
    Download
  • Bupropion HCL ER National Contracts Solicitation SPE2D2-21-R-0105.pdf

    1.6 MBAdded in Solicitation version 2Posted
    Download

Lifecycle

  1. 8
    Version 8PresolicitationArchived

    Bupropion HCL ER

    Notice 7765ef1337eb4ea0bf134c07227924ed on SAM.gov

  2. 2
    Version 2Solicitation

    Type changed from Presolicitation to Solicitation

    Bupropion HCL ER

    Notice dc424375d68442709bb2d8b46f4aabcc on SAM.gov

  3. 3
    Version 3Solicitation

    Bupropion HCL ER

    Notice 664bf4e5db31424f8048839f11e9e0da on SAM.gov

  4. 4
    Version 4Solicitation

    Bupropion HCL ER

    Notice 833b3fd5d9cc431d97fab24e0626576f on SAM.gov

  5. 5
    Version 5Solicitation

    Bupropion HCL ER

    Notice b63a57741173444ca28e6aa0953f58af on SAM.gov

  6. 6
    Version 6SolicitationCurrent

    Bupropion HCL ER

    Notice d2713ea231544d89b653a39e3fbe278e on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

SPE2D2-21-R-0105

Archive Date

Feb 15, 2027

Office Address

PHILADELPHIA, PA, 19111